Key result
A risk scoring system using APACHE II, qSOFA, serum albumin, and disease type predicted ICU mortality, with scores of 0 to 5-6 corresponding to approximately 10% to 65% risk of death.
Why the study?
Predicting the clinical progression of ICU patients is crucial for survival and prognosis, motivating the development of mortality risk scoring and ICU length of stay prediction models.
Can a risk scoring system and prediction model accurately predict mortality and length of stay in critically ill patients receiving parenteral nutrition?
Observational (n=445)
Can a risk scoring system and prediction model accurately predict mortality and length of stay in critically ill patients receiving parenteral nutrition?
A newly developed risk scoring system and prediction equation can help clinicians estimate mortality risk and ICU length of stay for critically ill patients on parenteral nutrition.
May aid mortality risk stratification in ICU parenteral nutrition patients; leaves open prospective validation before clinical use.
Predicting the clinical progression of intensive care unit (ICU) patients is crucial for survival and prognosis. Therefore, this retrospective study aimed to develop the risk scoring system of mortality and the prediction model of ICU length of stay (LOS) among patients admitted to the ICU. Data from ICU patients aged at least 18 years who received parenteral nutrition support for ≥50% of the daily calorie requirement from February 2014 to January 2018 were collected. In-hospital mortality and log-transformed LOS were analyzed by logistic regression and linear regression, respectively. For calculating risk scores, each coefficient was obtained based on regression model. Of 445 patients, 97 patients died in the ICU; the observed mortality rate was 21.8%. Using logistic regression analysis, APACHE II score (15-29: 1 point, 30 or higher: 2 points), qSOFA score ≥ 2 (2 points), serum albumin level < 3.4 g/dL (1 point), and infectious or respiratory disease (1 point) were incorporated into risk scoring system for mortality; patients with 0, 1, 2-4, and 5-6 points had approximately 10%, 20%, 40%, and 65% risk of death. For LOS, linear regression analysis showed the following prediction equation: log(LOS) = 0.01 × (APACHE II) + 0.04 × (total bilirubin) - 0.09 × (admission diagnosis of gastrointestinal disease or injury, poisoning, or other external cause) + 0.970. Our study provides the mortality risk score and LOS prediction equation. It could help clinicians to identify those at risk and optimize ICU management.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2021) conducted an observational in Critically ill patients receiving parenteral nutrition (n=445). Risk factors (APACHE II, qSOFA, serum albumin, infectious or respiratory disease) was evaluated on In-hospital mortality and ICU length of stay. A risk scoring system using APACHE II, qSOFA, serum albumin, and disease type predicted ICU mortality, with scores of 0 to 5-6 corresponding to approximately 10% to 65% risk of death.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: